Commitments and Contingencies (Details)		1 Months Ended			10 Months Ended	12 Months Ended	14 Months Ended
	Sep. 03, 2014 USD ($) shares	Jul. 31, 2020 USD ($)	Mar. 31, 2020 USD ($) $ / shares	Jan. 31, 2020 USD ($)	Oct. 31, 2020 USD ($) $ / ft²	Dec. 31, 2021 USD ($) m²	Dec. 31, 2021 USD ($) m² $ / ft²
Other Commitments [Line Items]
Commitments related to agreements						$ 100,000	$ 100,000
Maximum payment for commitment milestones						$ 7,900,000
Percentage for royalties						6.00%
Payments of milestone amount						$ 197,000
Office space (in Square Meters) | m²						6,200	6,200
Rent Expense Per Month					$ 11,883		$ 11,108
Rent Expense per Square Foot | $ / ft²					23.00		21.50
Cash paid to acquire Hy Biopharma intangible asset	$ 275,000
Shares issued in connection with Hy BioPharma asset purchase agreement (in Shares) | shares	184,912
Fair value of shares issued in connection with Hy BioPharma asset purchase	$ 3,750,000		$ 1,956,182
Effective price per share (in Dollars per share) | $ / shares			$ 2.56
Additional Payments						$ 5,000,000.0
Ownership of company outstanding						19.90%
Emergent Biosolutions [Member]
Other Commitments [Line Items]
Amount of damages to be recovered		$ 19,000,000
Invoices		$ 331,000
Minimum [Member]
Other Commitments [Line Items]
Authorized shares to be issued				$ 5,000
Maximum [Member]
Other Commitments [Line Items]
Authorized shares to be issued				$ 500,000